Literature DB >> 9223108

Changes in apoptosis of human polymorphonuclear granulocytes with aging.

T Fülöp1, C Fouquet, P Allaire, N Perrin, G Lacombe, J Stankova, M Rola-Pleszczynski, D Gagné, J R Wagner, A Khalil, G Dupuis.   

Abstract

Many alterations with aging occur at the cellular and organic levels in the immune system ultimately leading to a decrease in the immune response. Our aim in the present work was to study apoptosis of polymorphonuclear granulocytes (PMN) with aging under various stimulations since apoptosis might play an important role in several pathologies encountered with aging. The PMN of healthy young (20-25 years) and elderly (65-85 years) subjects were examined after 24 h of sterile culture with and without stimulation. The stimulating agents included: phorbol myristate acetate (PMA), hydrogen peroxide (H2O2), N-formyl-methionyl-leucyl phenylalanine (FMLP), granulocyte-macrophage colony stimulating factor (GM-CSF), reduced glutathione (GSH), lipopolysaccharide (LPS) and interleukin 2 (IL-2). Apoptosis was assessed by traditional staining of the plates, by flow cytometric staining and DNA gel electrophoresis. It was found that without stimulation the susceptibility of PMN to apoptosis was slightly increased with aging. Under various stimulations, such as PMA. H2O2, apoptosis was almost 100%, while the treatment by FMLP, oxLDL and GSH did not change its extent in PMN obtained either from young or elderly subjects. Marked age-related changes were observed in the extent of apoptosis under stimulation with GM-CSF, IL-2 and LPS. These agents were able to significantly prevent apoptosis in PMN of young subjects, while only the GM-CSF was able to slightly modulate it in neutrophils of elderly subjects. From these results, we suggest that changes in apoptosis of PMN with aging could play a role in the increased incidence of certain immune system related pathologies of aging, such as cancer, infections and autoimmune disorders.

Entities:  

Mesh:

Year:  1997        PMID: 9223108     DOI: 10.1016/s0047-6374(96)01881-7

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  24 in total

Review 1.  Review article: ageing and the neutrophil: no appetite for killing?

Authors:  S Butcher; H Chahel; J M Lord
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

Review 2.  Age-related changes in immune function: effect on airway inflammation.

Authors:  Paula J Busse; Sameer K Mathur
Journal:  J Allergy Clin Immunol       Date:  2010-10       Impact factor: 10.793

Review 3.  Multiple sclerosis in the elderly patient.

Authors:  Amer Awad; Olaf Stüve
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

Review 4.  Innate immunity and aging.

Authors:  Christian R Gomez; Vanessa Nomellini; Douglas E Faunce; Elizabeth J Kovacs
Journal:  Exp Gerontol       Date:  2008-06-11       Impact factor: 4.032

Review 5.  Role of allergen sensitization in older adults.

Authors:  Ravi K Viswanathan; Sameer K Mathur
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

6.  Changes in immune function in asthma in the elderly.

Authors:  Sameer K Mathur; Sharmilee M Nyenhuis
Journal:  Aging health       Date:  2009-09

7.  Aging-related Atg5 defect impairs neutrophil extracellular traps formation.

Authors:  Fengying Xu; Chengmi Zhang; Zui Zou; Erica K Y Fan; Linsong Chen; Yuehua Li; Timothy R Billiar; Mark A Wilson; Xueyin Shi; Jie Fan
Journal:  Immunology       Date:  2017-05-16       Impact factor: 7.397

8.  Spontaneous and Fas-induced apoptotic cell death in aged neutrophils.

Authors:  C Tortorella; G Piazzolla; F Spaccavento; S Pece; E Jirillo; S Antonaci
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

Review 9.  Role of Immune Aging in Susceptibility to West Nile Virus.

Authors:  Yi Yao; Ruth R Montgomery
Journal:  Methods Mol Biol       Date:  2016

Review 10.  Inflammaging and the Lung.

Authors:  Elizabeth J Kovacs; Devin M Boe; Lisbeth A Boule; Brenda J Curtis
Journal:  Clin Geriatr Med       Date:  2017-07-14       Impact factor: 3.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.